Welcome to our dedicated page for Elbit Sys SEC filings (Ticker: ESLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Elbit Systems Ltd. filings document a foreign private issuer whose disclosures center on defense technology operations, financial reporting and material contract announcements. Form 6-K current reports furnish company press releases covering quarterly and annual results, conference-call notices, annual report filing notices, and contract awards for systems such as PULS rocket artillery, UT30MK2 turrets, airborne munitions and Iron Fist active protection systems.
The company’s Form 20-F reporting framework covers its consolidated business, segment and geographic activity, governance, risk factors and capital structure. Its regulatory record also reflects dual trading on Nasdaq and the Tel Aviv Stock Exchange, with filings submitted under the Form 20-F foreign issuer regime rather than Form 40-F.
Elbit Systems executive Oren Yaacov Sabag, an Executive Vice President, exercised 10,000 employee stock options on April 9, 2026 at an exercise price of $134.34 per share, receiving an equal number of ordinary shares held in an employee benefit trust.
Of these shares, 1,496 were retained by Elbit Systems as payment of the option exercise price, while the remaining 8,504 shares were sold in the open market at $887.40 per share. Following these transactions, the trust held no shares from this option grant. The options had vested in four tranches between April 7, 2023 and April 7, 2026.
Elbit Systems Executive Vice President Ariel Jonathan exercised employee stock options for 9,000 ordinary shares at $134.34 per share, with the options and resulting shares held in an employee benefit trust. Of the acquired shares, 1,346 were retained by the company to pay the option exercise price and 7,654 shares were sold in the open market at $887.40 per share. Following these transactions, the trust no longer holds shares or options from this grant for Mr. Ariel.
Elbit Systems President and CEO Bezhalel Machlis reported a compensation-related option exercise and share sale through an employee benefit trust. On April 9, 2026, an employee stock option for 30,000 Ordinary Shares was exercised at $134.34 per share, with the options and resulting shares held in trust by IBI Trust Management for his benefit.
Following the exercise, 4,486 shares were retained by Elbit Systems to pay the option exercise price, and the remaining 25,514 shares were sold in open-market transactions at $887.40 per share. After these transactions, the trust’s position in these reported Ordinary Shares from this grant was reduced to zero, and no related derivative position remains visible in this filing.
Elbit Systems Ltd Executive Vice President Ran Kril reported an exercise-and-sale transaction involving employee stock options held in an employee benefit trust. He exercised 8,000 employee stock options at an exercise price of $134.34 per share, receiving the same number of ordinary shares indirectly through the trust. The company retained 1,197 shares to pay the option exercise price, and the remaining 6,803 shares were sold in the market at $887.40 per share. Following these transactions, no shares from this option grant remained in the trust.
Elbit Systems Executive Vice President Haim Daniel Delmar exercised employee stock options to acquire 9,000 ordinary shares of Elbit Systems Ltd. at $134.34 per share, held indirectly through an employee benefit trust.
The company retained 1,346 shares to pay the option exercise price, and the remaining 7,654 shares were sold in an open-market transaction at $887.40 per share. Following these transactions, the trust reported no remaining options or shares for this award.
Elbit Systems Ltd. reported a major new defense win, securing a contract worth approximately $750 million (€650 million) to supply its PULS rocket artillery systems to the Hellenic Armed Forces. The deal is part of an agreement between the Israeli and Hellenic defense ministries.
The contract will be executed over 4 years and followed by an additional ten-year support period. It covers PULS launchers and a broad munitions package, including training rockets, precision‑guided rockets for various ranges and loitering munitions. Elbit Systems will work with Greek industries on production, including technology transfer and know‑how sharing.
The company describes PULS as a flexible, cost‑effective artillery solution adaptable to wheeled and tracked platforms. Elbit Systems, which reported $7,938.6 million in revenues and an $28.1 billion order backlog for the year ended December 31, 2025, views this contract as further strengthening its long‑standing relationship with Greece and adding to its European customer base.
Elbit Systems Ltd Executive Vice President Haim Daniel Delmar received an award of 5,000 employee stock options, indirectly held in an employee benefit trust managed by IBI Trust Management. The options have an exercise price of 912.6000 per share and are exercisable into 5,000 Ordinary Shares.
The options vest in three tranches: 40% on March 24, 2028, 30% on March 24, 2029, and 30% on March 24, 2030, and expire on June 24, 2031. The plan uses a net exercise mechanism, so the actual shares delivered upon exercise will likely be fewer than 5,000. Mr. Delmar is the sole beneficiary of the options.
Elbit Systems Ltd Executive Vice President Ariel Jonathan has filed an initial ownership report showing indirect holdings of employee stock options held in an employee benefit trust managed by IBI Trust Management. These options relate to ordinary shares of Elbit Systems.
The filing lists options over 9,000 underlying shares at an exercise price of 134.3400 per share expiring on July 7, 2027, and options over 40,000 underlying shares at 197.8200 per share expiring on December 19, 2028. Footnotes explain that the 2021 grant is largely vested, the remainder vesting on April 7, 2026, while the 2024 grant vests in stages from September 19, 2026 through September 19, 2028, and that a net exercise mechanism will generally reduce the number of shares actually received upon exercise.
Elbit Systems Ltd Executive Vice President Haim Daniel Delmar reports existing stock option holdings. The Form 3 shows indirect beneficial ownership of employee stock options over 9,000 ordinary shares at an exercise price of $134.34 expiring on July 7, 2027, and 40,000 shares at $197.82 expiring on December 19, 2028. These options were granted in 2021 and 2024 with vesting schedules through April 7, 2026 and from September 19, 2026 to September 19, 2028, and are subject to a net exercise mechanism that typically delivers fewer shares than the underlying option amount.
Elbit Systems Ltd Executive Vice President Oren Yaacov Sabag filed an initial ownership report showing indirect holdings of employee stock options held in an employee benefit trust managed by IBI Trust Management.
He holds options over 10,000 ordinary shares with an exercise price of $134.34 expiring on July 7, 2027, and options over 45,000 ordinary shares with an exercise price of $197.82 expiring on December 19, 2028.
Footnotes explain that a 2021 option grant is 80% vested, with the remaining 20% vesting on April 7, 2026, and that exercises use a net exercise mechanism so the actual shares received will be fewer than the underlying amounts. A 2024 grant vests in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028. Mr. Sabag is the sole beneficiary of these options.